255 related articles for article (PubMed ID: 22921081)
21. Structure activity studies on the crinane alkaloid apoptosis-inducing pharmacophore.
McNulty J; Nair JJ; Bastida J; Pandey S; Griffin C
Nat Prod Commun; 2009 Apr; 4(4):483-8. PubMed ID: 19475990
[TBL] [Abstract][Full Text] [Related]
22. C1,C2-ether derivatives of the Amaryllidaceae alkaloid lycorine: retention of activity of highly lipophilic analogues against cancer cells.
Dasari R; Banuls LM; Masi M; Pelly SC; Mathieu V; Green IR; van Otterlo WA; Evidente A; Kiss R; Kornienko A
Bioorg Med Chem Lett; 2014 Feb; 24(3):923-7. PubMed ID: 24393582
[TBL] [Abstract][Full Text] [Related]
23. Screening for cytotoxic activity of extracts and isolated alkaloids from bulbs of Hippeastrum vittatum.
Silva AF; de Andrade JP; Machado KR; Rocha AB; Apel MA; Sobral ME; Henriques AT; Zuanazzi JA
Phytomedicine; 2008 Oct; 15(10):882-5. PubMed ID: 18304791
[TBL] [Abstract][Full Text] [Related]
24. Cytotoxic alkaloids from the whole plants of Zephyranthes candida.
Luo Z; Wang F; Zhang J; Li X; Zhang M; Hao X; Xue Y; Li Y; Horgen FD; Yao G; Zhang Y
J Nat Prod; 2012 Dec; 75(12):2113-20. PubMed ID: 23190013
[TBL] [Abstract][Full Text] [Related]
25. Four New Amaryllidaceae Alkaloids from Lycoris radiata and Their Cytotoxicity.
Ang S; Liu XM; Huang XJ; Zhang DM; Zhang W; Wang L; Ye WC
Planta Med; 2015 Dec; 81(18):1712-8. PubMed ID: 26252827
[TBL] [Abstract][Full Text] [Related]
26. Structure-activity studies on the lycorine pharmacophore: A potent inducer of apoptosis in human leukemia cells.
McNulty J; Nair JJ; Bastida J; Pandey S; Griffin C
Phytochemistry; 2009 May; 70(7):913-9. PubMed ID: 19464034
[TBL] [Abstract][Full Text] [Related]
27. Antiproliferative amaryllidaceae alkaloids isolated from the bulbs of Sprekelia formosissima and Hymenocallis x festalis.
Hohmann J; Forgo P; Molnár J; Wolfard K; Molnár A; Thalhammer T; Máthé I; Sharples D
Planta Med; 2002 May; 68(5):454-7. PubMed ID: 12058326
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of Amaryllidaceae Constituents and Unnatural Derivatives.
Ghavre M; Froese J; Pour M; Hudlicky T
Angew Chem Int Ed Engl; 2016 May; 55(19):5642-91. PubMed ID: 26969844
[TBL] [Abstract][Full Text] [Related]
29. Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents.
Ingrassia L; Lefranc F; Dewelle J; Pottier L; Mathieu V; Spiegl-Kreinecker S; Sauvage S; El Yazidi M; Dehoux M; Berger W; Van Quaquebeke E; Kiss R
J Med Chem; 2009 Feb; 52(4):1100-14. PubMed ID: 19199649
[TBL] [Abstract][Full Text] [Related]
30. Anticancer potential of Amaryllidaceae alkaloids evaluated by screening with a panel of human cells, real-time cellular analysis and Ehrlich tumor-bearing mice.
Havelek R; Muthna D; Tomsik P; Kralovec K; Seifrtova M; Cahlikova L; Hostalkova A; Safratova M; Perwein M; Cermakova E; Rezacova M
Chem Biol Interact; 2017 Sep; 275():121-132. PubMed ID: 28756149
[TBL] [Abstract][Full Text] [Related]
31. Antineoplastic agents. 550. Synthesis of 10b(s)-epipancratistatin from (+)-narciclasine.
Pettit GR; Melody N; Herald DL; Knight JC; Chapuis JC
J Nat Prod; 2007 Mar; 70(3):417-22. PubMed ID: 17346078
[TBL] [Abstract][Full Text] [Related]
32. Narciclasine-4-
Katoch D; Kumar D; Padwad YS; Singh B; Sharma U
Nat Prod Res; 2020 Jan; 34(2):233-240. PubMed ID: 30636443
[TBL] [Abstract][Full Text] [Related]
33. Human cytochrome P450 liability studies of trans-dihydronarciclasine: a readily available, potent, and selective cancer cell growth inhibitor.
McNulty J; Thorat A; Vurgun N; Nair JJ; Makaji E; Crankshaw DJ; Holloway AC; Pandey S
J Nat Prod; 2011 Jan; 74(1):106-8. PubMed ID: 21105682
[TBL] [Abstract][Full Text] [Related]
34. Amaryllidaceae alkaloids: Absolute configuration and biological activity.
Cimmino A; Masi M; Evidente M; Superchi S; Evidente A
Chirality; 2017 Sep; 29(9):486-499. PubMed ID: 28649696
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of aromatic analogues of conduritol F, L-chiro-inositol, and dihydroconduritol F structurally related to the amaryllidaceae anticancer constituents.
Kireev AS; Nadein ON; Agustin VJ; Bush NE; Evidente A; Manpadi M; Ogasawara MA; Rastogi SK; Rogelj S; Shors ST; Kornienko A
J Org Chem; 2006 Jul; 71(15):5694-707. PubMed ID: 16839151
[TBL] [Abstract][Full Text] [Related]
36. Alkaloids of the South African Amaryllidaceae: a review.
Nair JJ; Bastida J; Codina C; Viladomat F; van Staden J
Nat Prod Commun; 2013 Sep; 8(9):1335-50. PubMed ID: 24273880
[TBL] [Abstract][Full Text] [Related]
37. synthesis and biological evaluation of fully functionalized seco-pancratistatin analogues.
McNulty J; Nair JJ; Griffin C; Pandey S
J Nat Prod; 2008 Mar; 71(3):357-63. PubMed ID: 18225861
[TBL] [Abstract][Full Text] [Related]
38. Chemoenzymatic synthesis of Amaryllidaceae constituents and biological evaluation of their C-1 analogues. The next generation synthesis of 7-deoxypancratistatin and trans-dihydrolycoricidine.
Collins J; Rinner U; Moser M; Hudlicky T; Ghiviriga I; Romero AE; Kornienko A; Ma D; Griffin C; Pandey S
J Org Chem; 2010 May; 75(9):3069-84. PubMed ID: 20373760
[TBL] [Abstract][Full Text] [Related]
39. Acetylcholinesterase inhibition within the lycorine series of Amaryllidaceae alkaloids.
Nair JJ; van Staden J
Nat Prod Commun; 2012 Jul; 7(7):959-62. PubMed ID: 22908593
[TBL] [Abstract][Full Text] [Related]
40. In vivo Cytotoxicity Studies of Amaryllidaceae Alkaloids.
Nair JJ; Bastida J; van Staden J
Nat Prod Commun; 2016 Jan; 11(1):121-32. PubMed ID: 26996036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
